198 related articles for article (PubMed ID: 16205076)
1. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
Marzano AV; Ghislanzoni M; Gianelli U; Caputo R; Alessi E; Berti E
Dermatology; 2005; 211(3):281-5. PubMed ID: 16205076
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
Kim SK; Kim YC; Kang HY
J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
6. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
[TBL] [Abstract][Full Text] [Related]
7. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
8. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
Kasuya A; Hirakawa S; Tokura Y
Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
[TBL] [Abstract][Full Text] [Related]
10. CD8+ lymphomatoid papulosis and its differential diagnosis.
Magro CM; Crowson AN; Morrison C; Merati K; Porcu P; Wright ED
Am J Clin Pathol; 2006 Apr; 125(4):490-501. PubMed ID: 16627259
[TBL] [Abstract][Full Text] [Related]
11. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
Fika Z; Karkos PD; Badran K; Williams RE
J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients.
Hagiwara M; Takata K; Shimoyama Y; Yamamoto K; Takahashi E; Asano N; Iwase Y; Okazaki Y; Tamada Y; Yoshino T; Tomita Y; Nakamura S
Cancer Sci; 2009 Jan; 100(1):33-41. PubMed ID: 19018763
[TBL] [Abstract][Full Text] [Related]
17. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
18. Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.
Robson A; Assaf C; Bagot M; Burg G; Calonje E; Castillo C; Cerroni L; Chimenti N; Dechelotte P; Franck F; Geerts M; Gellrich S; Goodlad J; Kempf W; Knobler R; Massone C; Meijer C; Ortiz P; Petrella T; Pimpinelli N; Roewert J; Russell-Jones R; Santucci M; Steinhoff M; Sterry W; Wechsler J; Whittaker S; Willemze R; Berti E
Histopathology; 2015 Oct; 67(4):425-41. PubMed ID: 24438036
[TBL] [Abstract][Full Text] [Related]
19. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].
Gardette E; Moguelet P; Barete S; Frances C; Senet P
Ann Dermatol Venereol; 2016 Dec; 143(12):846-851. PubMed ID: 27161647
[TBL] [Abstract][Full Text] [Related]
20. [Clinical, morphologic and immunophenotypic data based on 10 cases of canine muco-cutaneous epidermotropic T-lymphoma (analogous to Mycosis Funcgoïde). Important of an animal model of spontaneous pathology].
Magnol JP; Ghernati I; Marchal T; Chabanne L; Delverdier A; Fournel C
Bull Acad Natl Med; 1996 Feb; 180(2):449-62. PubMed ID: 8705383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
